HHS and FDA Alzheimers Issues
Active 2025–2026.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | RUBICON ADVISORS, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2026 | RUBICON ADVISORS, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2025 | RUBICON ADVISORS, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2025 | RUBICON ADVISORS, LLC |
3rd Quarter (July 1 - Sep 30) AMENDED |
— | |
| 2025 | RUBICON ADVISORS, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$20,000 | |
| 2025 | RUBICON ADVISORS, LLC |
1st Quarter (Jan 1 - Mar 31) Registration |
— |
| Firm | Filings | Amount |
|---|---|---|
| RUBICON ADVISORS, LLC | 6 | $20,000 |
| Issue | Activities |
|---|---|
| Health Issues | 5 |
| Pharmacy | 1 |